RBFOX3 and ischemia: As presented in Figures 1C,D, a semi-brain section screening was used, and the results showed that ischemia intrusion distinctly reduced the number of cells with immunoreactive NeuN, and this result was prevented by EGCG administration, indicating that EGCG treatment protected poststroke neuronal loss, which was consistent with the TTC results (Figures 1A,B).